Lei Yi

Lei Yi


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Bioactive Materials
Verified
Journal Article
Open access
RWRenwen Wan
Renwen Wan
ZLZhiheng Lin
Zhiheng Lin
MXMowen Xu
Mowen Xu
WLWei Luo
Wei Luo
HJHengjie Jia
Hengjie Jia
ZZZhijie Zhao
Zhijie Zhao
Diabetic wound healing is a significant complication of diabetes mellitus, characterized by prolonged healing times, heightened infection risks, and potential amputations, necessitating innovative therapeutic approaches. This study aims to evaluate the efficacy of a novel injectable hydrogel, AP@HA-Si InjGel, which combines hyaluronic acid, silanol, and bioactive compounds to promote wound healing in diabetic patients. Utilizing a combination of in vitro assays, diabetic mouse models, and advanced techniques such as single-cell RNA sequencing, we demonstrated that AP@HA-Si InjGel significantly accelerates wound closure, enhances collagen deposition, and modulates macrophage polarization towards a pro-healing M2 phenotype while suppressing the inflammatory M1 phenotype. The hydrogel exhibited excellent biocompatibility with over 90 % cell viability and significant antioxidant properties, reducing reactive oxygen species accumulation. Histological analysis confirmed that AP@HA-Si InjGel promoted neovascularization and improved extracellular matrix remodeling, thereby enhancing tissue regeneration. Furthermore, single-cell RNA sequencing revealed distinct macrophage subtypes, with an increased proportion of M2 macrophages and a favorable differentiation trajectory towards enhanced wound healing. Overall, these findings highlight the therapeutic potential of AP@HA-Si InjGel as a comprehensive strategy for diabetic wound management, warranting further exploration in clinical settings to address the growing challenge of impaired wound healing in diabetic patients.

2 January 2025 in Burns & Trauma
Verified
Journal Article
Open access
XHXiao-Qin Huang
Xiao-Qin Huang
HZHaoran Zhang
Haoran Zhang
YLYuhong Luo
Yuhong Luo
XYXin Yi
Xin Yi
ZZZengding Zhou
Zengding Zhou
LYLei Yi
Lei Yi
Background: Lipopolysaccharide (LPS)-induced apoptosis of lung microvascular endothelial cells (ECs) is the main reason of lung edema and acute lung injury (ALI) in septic conditions. Telocytes (TCs) are a distinct type of interstitial cells found around the lung microvasculature, which may protect ECs through the release of shed vesicles. However, whether TCs protect against LPS-induced EC apoptosis and ALI has not been determined. Methods: The protective effects of TCs on ECs were assessed in vitro using transwell assays and flow cytometry, and in vivo using an LPS-induced mouse ALI model. RNA sequencing was used to identify miRNA-146a-5p as a key component of TC-derived exosomes. The functions of miRNA-146a-5p were further evaluated by western blotting, flow cytometry, and transendothelial electrical resistance measurements. Results: We demonstrated that LPS stimulation induced the secretion of active exosomes from TCs, which inhibited LPS-mediated apoptosis of ECs and reduced ALI in mice. Moreover, miRNA-146a-5p was identified as the main bioactive molecule in TC-derived exosomes, capable of inhibiting LPS-induced caspase-3 activation and apoptosis in ECs. Conclusions: Our results indicate that TCs effectively prevent LPS-induced EC apoptosis and ALI through the release of exosomes, with subsequent activation of the miRNA-146a-5p/caspase-3 signaling pathway in ECs.

16 December 2024 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
YZYanhai Zuo
Yanhai Zuo
LYLei Yi
Lei Yi


2 July 2024 in Medical Hypotheses
Verified
Journal Article
Closed access
XSXu Sun
Xu Sun
ZZZengding Zhou
Zengding Zhou
YLYao Li
Yao Li
FGFeng Guo
Feng Guo
LYLei Yi
Lei Yi

26 June 2026 in Chinese Journal of Traumatology
Verified
Journal Article
Open access
YZYanhai Zuo
Yanhai Zuo
JQJun Qian
Jun Qian
PLPan Long
Pan Long
XZXinchu Zhou
Xinchu Zhou
LYLei Yi
Lei Yi
Pigs have long been used as an animal model for fibula flaps. However, the vascular anatomy of the pig fibula has not been described comprehensively. This study was designed to explore the vascular anatomy of the pig fibula and explore the feasibility of using pigs as animal models for surgical training. Twenty fresh cadaveric hindlimbs from hybrid pigs (Shanghai White pig) were used in this study. The arteries were infused with black lard. The origin, course, and branches of the vessels nourishing the fibula were observed in 15 samples. The primary parameters included variability in vessel anatomy and measurements. Surgical procedures to harvest the fibula flap were performed on 5 samples. Three types of fibular arteries branch into the fibula, all of which are located behind the interosseous membrane. The pig fibular artery exhibited high variation and was classified into 3 types according to its branching patterns. The operation was performed in the lateral position through the posterior-lateral intermuscular septum. The fibular arteries were easily exposed. After the osteotomy was performed, the fibula was rotated outward to isolate the medial and posterior sides of the fibula in turn. Although the fibular arteries of pigs and humans are distinct, possibly due to evolutionary and/or functional adaptations, pigs can be used as an animal model for surgical training of fibula flaps.